Home | Applications

Product # 11110 - Estradiol (E2) Enzyme Immunoassay
  1. Tsang, B.K., Armstrong, D.T. and Whitfield, J.F., Steroid biosynthesis by isolated human ovarian follicular cells in vitro, J. Clin. Endocrinol. Metab., 1980; 51: 1407-1411.
  2. Gore-Langton, R.E. and Armstrong, D.T., Follicular steroidogenesis and its control. In: Knobil, E., and Neill, J. et al., ed. The Physiology of Reproduction. Raven Press, New York; 1988: 331-385.
  3. Hall, P.F., Testicular steroid synthesis: Organization and regulation. In: Knobil, E., and Neill, J. et al., ed. The Physiology of Reproduction. Raven Press, New York; 1988: 975-998.
  4. Siiteri, P.K., Murai, J.T., Hammond, G.L., Nisker, J.A., Raymoure, W.J. and Kuhn, R.W., The serum transport of steroid hormones, Rec. Prog. Horm. Res., 1982; 38: 457-510.
  5. Baird, D.T., Ovarian steroid secretion and metabolism in women. In: James, V.H.T., Serio, M. and Giusti, G., eds. The Endocrine Function of the Human Ovary. Academic Press, New York; 1976: 125-133.
  6. McNatty, K.P., Baird, D.T., Bolton, A., Chambers, P., Corker, C.S. and McLean, H., Concentration of oestrogens and androgens in human ovarian venous plasma and follicular fluid throughout the menstrual cycle, J. Endocrinol., 1976; 71: 77-85.
  7. Abraham, G.E., Odell, W.D., Swerdloff, R.S., and Hopper, K., Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone and estradiol-17β during the menstrual cycle, J. Clin. Endocrinol. Metab., 1972; 34: 312-318.
  8. March, C.M., Goebelsmann, U., Nakumara, R.M., and Mishell, D.R. Jr., Roles of estradiol and progesterone in eliciting the midcycle luteinizing hormone and follicle-stimulating hormone surges. J. Clin. Endocrinol. Metab., 1979; 49: 507-513.
  9. Simpson, E.R., and MacDonald, P.C., Endocrinology of pregnancy. In: Williams, R.H., ed., Textbook of Endocrinology. Saunders Company, Philadelphia; 1981: 412-422.
  10. Jenner, M.R., Kelch, R.P., Kaplan, S.L. and Grumbach, M.M., Hormonal changes in puberty: IV. Plasma estradiol, LH, and FSH in prepubertal children, pubertal females and in precocious puberty, premature thelarche, hypogonadism and in a child with feminizing ovarian tumor. J. Clin. Endocrinol. Metab., 197 2; 34: 521-530.
  11. Goldstein, D., Zuckerman, H., Harpaz, S., et al., Correlation between estradiol and progesterone in cycles with luteal phase deficiency. Fertil. Steril., 1982; 37: 348-354.
  12. Kirschner, M.A., The role of hormones in the etiology of human breast cancer. Cancer, 1977; 39: 2716-2726.
  13. Odell, W.D. and Swerdloff, R.S., Abnormalities of gonadal function in men. Clin. Endocr., 1978; 8: 149-180.
  14. MacDonald, P.C., Madden, J.D., Brenner, P.F., Wilson, J.D. and Siiteri, P.K., Origin of estrogen in normal men and in women with testicular feminization, J.Clin. Endocrinol. Metabl., 1979; 49: 905-916.
  15. Fishel, S.B., Edwards, R.G., Purdy, J.M., Steptoe, P.C., Webster, J., Walters, E., Cohen, J., Fehilly, C. Hewitt, J., and Rowland, G., Implantation, abortion and birth after in vitro fertilization using the natural menstrual cycle or follicular stimulation with clomiphene citrate and human menopausal gonadotropin, J. In Vitro Fertil. Embryo Transfer, 1985; 2: 123-131.
  16. Ratcliffe, W.A., Carter, G.D., Dowsett, M., et al., Oestradiol assays: applications and guidelines for the provision of a clinical biochemistry service, Ann. Clin. Biochem., 1988; 25:466-483.
  17. Tietz, N.W. ed., Clinical Guide to Laboratory Tests, 3rd Edition, W.B. Saunders, Co., Philadelphia, 1995: 216-217.
  18. USA Center for Disease Control/National Institute of Health Manual,
Product # 11130 - Progesterone Enzyme Immunoassay
  1. Radwanska, E., Frankenberg, J., and Allen, E., Plasma progesterone levels in normal and abnormal early human pregnancy. Fertility and Sterility, 1978; 30, 398-402.
  2. Autrere,M.B., and Benson, H., Progesterone: An overview and recent advances, J. Par. Sci., 1976; 65: 783-800.
  3. March, C.M., Goebelsmann, U., Nakamura, R.M., and Mishell, D.R. Jr., Roles of estradiol and progesterone in eliciting the midcycle luteinizing hormone and follicle-stimulating hormone surges, J. Clin. Endo. Metab., 1979; 49, 507-513.
  4. Ross, G.T., Vande Wiele, R.L., and Frantz, A.G., The Ovaries and the breasts. In: Williams, R.H., ed., Textbook of Endocrinology. Saunders Company, Philadelphia; 1981: 355- 411.
  5. Chattoraj, S.C., Endocrine function. In: Tietz, N.W., ed., Fundamentals of Clinical Chemistry. Saunders Company, Philadelphia; 1976: 699-823.
  6. Shepard, M.K., and Senturia, Y.D., Comparison of serum progesterone and endometrial biopsy for confirmation of ovulation and evaluation of luteal function. Fertility and Sterility, 1977; 28: 541-548.
  7. Johansson, E.D.B., and Jonasson, L.-E., Progesterone levels in amniotic fluid and plasma from women: I. Levels during normal pregnancy. Acta Obstet. Gynec. Scand., 1971; 50: 339-343.
  8. USA Center for Disease Control/National Institute of Health Manual,
Product # 11150 - Testosterone Enzyme Immunoassay
  1. Chen, A., Bookstein, J.J., Meldrum, D.R., Diagnosis of a testosterone-secreting adrenal adenoma by selective venous catheterization. Fertil. Steril., 1991; 55: 1202-1203.
  2. Granoff, A.B. and Abraham, G.E., Peripheral and adrenal venous levels of steroids in a patient with virilizing adrenal adenoma. Obstet. Gynecol., 1979; 53:111-115.
  3. Bricaire, C., Raynaud, A., Benotmane, A., et al., Selective venous catheterization in the evaluation of hyperandrogenism.
  4. Endocrinol Invest., 1991; 14: 949-956.
  5. Heinonen, P.K., Androgen production by epithelial ovarian tumours in post-menopausal women. Maturitas, 1991; 13: 117- 117-122.
  6. Tietz, N.W. ed., Clinical Guide to Laboratory Tests, 3rd Edition, W.B. Saunders, Co., Philadelphia, 1995: 578-580.
  7. USA Center for Disease Control/National Institute of Health Manual,
Product # 11170 - Myoglobin Enzyme Immunoassay ELISA Kit
  1. Kagen, L.J.: Myoglobin: Methods and Diagnostic Uses, CRC Crit. Rev. Clin. Lab. Sci., 2:273; (1978).
  2. Juronen, E.L., Viikmaa, M.H., and Mikelsarr, A.V.N.: Rapid, simple and sensitive antigen capture ELISA for the quantitation of myoglobin using monoclonal antibodies, J. Imm. Meth.: 111, 109; (1988).
  3. Chapelle JP. et al.: Serum myoglobin determinations in the assessment of acute myocardial infarction. Eur. Heart Journal, 3:122, (1982).
  4. Cairns, J.P., et.al.: Usefulness of serial determinations of myoglobin and creatine kinase in serum compared for assessment of acute myocardial infarction, Clin. Chem. News, 29: 469, (1983).
  5. Silva, D.P., et.al.: Development and application of antibodies to human cardiac myoglobin in rapid fluolrescence immunoassay, Clin. Chem., 37: 1356, (1991).
  6. Ellis AK.: Patters of myoglobin release after reperfusion of injured myocardium. Clin. Chem., 72:639, (1985).
  7. Mair J. et al.: Rapid diagnosis of myocardial infarction by immunoturbidimetric myoglobin measurement (letter). Lancet, ;337:1343, (1991).
  8. Chapelle, J.P.: Myoglobin. Clin. Chem. News, 17:22, (1991).
  9. Hamfelt, A., et. al.: Use of biochemical tests for myocardial infarction in the county of Vasternorrland, a clinical chemistry routine for the diagnosis of myocardial infarction. Scand. J. Clin. Lab. Invest. Suppl., 200:20, (1990).
  10. Tucker, J.F., et.al.: Early diagnostic efficiency of cardiac troponin I and Troponin T for acute myocardial infarction, Academic Emergency Medicine: 4(1): 13-21; (1997).
  11. de Winter, R.J., et.al.: Value of myoglobin, troponin T and CKMbmass in ruling out an acute myocardial infarction in the emergency room, Circulation: 92(12): 3401-7; (1995).
  12. Montague, C., Kircher, T.: Myoglobin in early evaluation of acute chest pain, Amer. J. Clin. Path.: 104(4): 472-6; (1995).
  13. Tucker, J.F., et.al., Value of serial myoglobin levels in the early diagnosis of patients admitted for acute myocardial infarction, Annals of Emergency Medicine: 24(4): 704-8; (1994).
  14. Roxin, L.E., et.al.: The value of serum myoglobin determinations in the early diagnosis of acute myocardial infarction, Acta Medica Scand.: 215(5): 417-25; (1984).
  15. Sylven, C., Bendz, R.: Myoglobin, creatine kinase and its isoenzyme MB in serum after acute myocardial infarction, Eur. J. Cardiol.: 8(4-5): 515-21; (1978).
  16. Norregaard-Hansen, K., et. al.: Early observations of S-myoglobin in the diagnosis of acute myocardial infarction. The influence of discrimination limit, analytical quality, patient
Product # 11190 - CRP (C-Reactive Protein) ELISA
  1. Schultz, D.R., and Arnold P.I.:
Product # 11210 - Creatine Kinase (CK-MB) Enzyme Immunoassay Test Kit
  1. Lee, T.H., Goldman, L., Serum enzyme assays in the diagnosis of acute myocardial infarction. Ann. Intern. Med., 1986; 105: 221-233.
  2. The best biochemical markers of myocardial infarction. Scripps News, 1996; 10: 1-4.
  3. Meerson, F.Z., Javich, M.P., Isoenzyme pattern and activity of myocardial creatine phosphokinase under heart adaptation to prolonged overload. Basic Res. Cardiol., 1982; 77: 349-358.
  4. Wu, A., Wang, X-M., Gornet, T.G., et al., Creatine kinase MB isoforms in patients with skeletal muscle injury: ramifications for early detection of acute myocardial infarction. Clin. Chem., 1992; 38: 2396-2400.
  5. Bhayana, V., Cohoe, S., Leung F.Y., et al., Diagnostic evaluation of creatine kinase-2 mass and creatine kinase-3 and -2 isoform ratios in early diagnosis of acute myocardial infarction. Clin. Chem., 1993; 39: 488-495.
  6. Mair, J., Morandell, D., Genser, N., et al., Equivalent early sensitivities of myoglobin, Creatine Kinase MB mass, Creatine Kinase isoform ratios, and cardiac Troponin I and T for acute myocardial infarction. Clin. Chem., 1995; 41: 1266-1272.
  7. Bokhari, A.M., Davies, J., Davies J., et al., Biochemical diagnosis of myocardial infarction within the thrombolytic time window. Int. J. Cardiol., 1995; 48: 249-254.
  8. Mair, J., Wagner, I., Jakob, G., et al., Different time courses of cardic contractile proteins after acute myocardial infarction. Clin. Chim. Acta., 1994; 231: 47-60.
  9. Levitt, M.A., Promes, S.B., Bullock, S., et al., Combined cardiac marker approach with adjunct two-dimensional echocardiography to diagnose acute myocardial infarction in the emergency department. Ann, Em. Med., 1996; 27: 1-7.
  10. Li, D., Jialal, I., Keffer J.H., Greater frequency of increased cardiac Troponin T than increased cardiac Troponin I in patients with chronid renal failure. Clin. Chem., 1996; 42: 114-115.
  11. Mair, J., Smidt, J., Lechleitner, P., et al., A decision tree for the early diagnosis of acute myocardial infarction in nontraumatic chest pain patient at hospital admission. Chest, 1995; 108:1502-1509.
  12. Yang, Z., Zhang, W., Liu Y., Prognostic efficacy of Troponin T measurement in angina pectoris. Chin. Med. J. (Engl), 1995; 108: 626-630.
  13. Engvall, E., Enzyme immunoassay ELISA and EMIT. In: Van Vunakis, H. and Langone, J.J. eds., Methods in Enzymol., Academic Press, New York, 1980; 70: 419-439.
  14. Uotila, M., Ruoslahti, E. and Engvall, E. Two-site sandwich enzyme immunoassay with monoclonal antibodies to human alpha-fetoprotein. J. Immunol. Methods, 1981; 42: 11-15.
  15. Tietz, N.W., ed., Clinical Guide to Laboratory Tests, 3rd Edition, W.B. Saunders, Co., Philadelphia, 1995: 180-186.
Product # 11230 - Human Fatty Acid-Binding Protein (H-FABP) ELISA.
  1. Trifonov IR, Katrukha AG, Iavelov IS, Averkov OV and Gratsianskii NA. Diagnostic value of heart fatty-acid binding protein in early hospitalized patients with non ST elevation acute coronary syndrome. Kardiologiia. 2003; 45(5):4-8.
  2. WodzigKW, Pelsers MM, van der Vusse GJ, Ross W and Glatz JF. One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein. Ann Clin Biochem. 1997 May; 34(Pt 3):263-8.
  3. Chan CP, Sum KW, Cheung KY, Glatz JF, Sanderson JE, Hempet A, Lehmann M, Renneberg I and Renneberg R. Development of a quantitative lateral-flow assay for rapid detection of fatty acid-binding protein. J Immunol Methods. 2003 Aug; 279(1-2):91-100.
  4. Ohkaru Y, Asayama K, Ishii H, Nishimura S, Sunahara N, Tanaka T and Kawamura K. Development of a sandwich enzyme-linked immunosorbent assay for the determination of human heart type fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart fatty acid-binding protein. J Immunol Methods. 1995 Jan 13;178(1):99-111.
  5. Pagani F, Bonora R, Bonetti G and Panteghini M. Evaluation of a sandwich enzyme-linked immunosorbent assay for the measurement of serum heart fatty acid-binding protein. Ann Clin Biochem. 2002 Jul; 37(Pt 4):404-5.
  6. Watanabe T, Ohkubo Y, Matsuoka H, Kimura H, Sakai Y, Ohkaru Y, Tanaka T and Kitaura Y. Development of a simple whole blood panel test for detection of human heart-type fatty acid-binding protein. Clin Biochem. 2001 Jun;34(4):257-63.
  7. Kleine AH, Glatz JF, Van Nieuwenhoven FA and Van der Vusse GJ. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem. 1992 Oct 21;116(1-2):155-62.
  8. Zimmermann-Ivol CG, Burkhard PR. Le Floch-Rohr J, Allard L, Hochstrasser DF, Sanchez J-C. Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study. Mol Cell Proteomics. 2003 Oct 26 [Epub]
Product # 21047 - BIOXYTECH®
1. Klumpp T and Bieth J (1979) "Automated measurement of the elastase-inhibitory capacity of plasma with a centrifugal analyzer" Clin. Chem. 25, 969-972.
2. Fujita J et al. (1990) "Evaluation of elastase and antielastase balance in patients with chronic bronchitis and pulmonary emphysema" Am Rev Respir Dis 142, 57-62.
3. Boudier C and Bieth J (1994) "Oxidized mucus proteinase inhibitor: a fairly potent neutrophil elastase inhibitor" Biochem J 303, 61-68.
4. Whiteman M et al. (1999) "Modulation of peroxynitrite- and hypochlorous acid-induced inactivation of α α1-antiproteinase by mercaptoethylguanidine" British J of Pharmacology 126, 1646-1652.
Product # 24317 - Cytochrome P450 2E1
Gillarm, E.M., et al. 1994. Arch. Biochem. Biophys. 312, 59.
Product # 24319 -
Holmes, W., et al. 1990. Br. J. Cancer 62, 209.
Product # 24320 -
Holmes, W., et al. 1990.Brit. J. Cancer 62, 209.
Product # 24321 -
Holmes, W., et al. 1990. Br. J. Cancer 62, 209.
Product # 25430 -
1.Tilly, J.L., and Tilly, K.I. 1995. Endocrinology 136, 242. Kassim, E.A. 1982. Microbiol. Immunol. 26, 449.
2.Kikuchi
Product # 25431 -
1.Tilly, J.L., and Tilly, K.I. 1995. Endocrinology 136, 242.
2.Beers, R.F., and Sizer, I.W. 1952. J. Biol. Chem. 195, 133.
Product # 25432 -
1.Tilly, J.L., and Tilly, K.I. 1995. Endocrinology 136, 242.
2.Bonaventura, J., et al. 1972. Arch. Biochem. Biophys. 150, 606.
Product # 25433 -
Smith, I.K., et al. 1988. Anal. Biochem. 175, 408.
Product # 25434 -
1.Kolm, R.H., et al. 1995. Biochem. J. 311, 453.
2.Kolm, R.H., et al. 1995. Protein Expr. Purif. 6, 265.
3.Stenberg, G., et al. 1992. Protein Expr. Purif. 3, 80.
4.Widersten, M., et al. 1991. Biochem. J. 276, 519.
Product # 25435 -
1.Kolm, R.H., et al.1995. Biochem. J. 311, 453.
2.Kolm, R.H., et al.1995. Protein Expr. Purif. 6, 265.
3.Stenberg, G., et al. 1992. Protein Expr. Purif. 3, 80.
4.Widersten, M., et al.1991. Biochem. J. 276, 519.
Product # 25436 -
1.Kolm, R.H., et al. 1995. Biochem. J. 311, 453.
2.Stenberg, G., et al. 1992. Protein Expression Purif. 3, 80.
3.Widersten, M., et al.1991. Biochem. J. 276, 519.
Product # 25437 -
1.Panasenko, O.M., et al. 1994. Free Radical Biol. Med. 16, 143.
2.Mulligan, M.S., et al. 1992. Br. J. Pharmacol. 107, 1159.
3.Sharonov, B.P., and Churilova, I.V. 1992. Biochem. Biophys. Res. Commun. 189, 1129.
Product # 26511 -
1. Miyoslu I, Sakai H. L-ergothimeme by microbial fermentation. IP patent 1968, number 450623 2
2. Yadan JC, Xu I., US Patent 5,438,151, 1995. Assignee: Oxis International
3. Hartman, P.E. L-ergothioneme as antioxidant. Meth Enzy 1990; 186.310-318.
4. Akanmu D. et al. The antioxidant action of l-ergothioneine. Arch Biochem Biophys 1991; 288: 10-16.
5. Aruoma OI et. al. Antioxidant Action of Ergothioneine: Assesment of Its Ability to Scanvenge Peroxynitrite. Biochem. Biophys. 1997; 231: 389-391
6. Aruoma O.I. Protection Against Oxidative Damage and Cell Death by the Natural Antioxidant Ergothioneine. Food & Chem Tox. 1999; 37: 1043-1053
7. Oxis Final Report, Preliminary toxicity study of ergothioneine/single dose study, June, 1997
8. Oxis Final Report, Preliminary toxicity study of ergothioneine 14 day study, June, 1997.
9. Melville D.B. L-ergothioneine. Vitam. & Hormone., 17:155?204.1958.
10. Shukla Y., Kulshrestha, O.P. and Khuteta K.P. L-ergothioneine content in normal and senile human cataractous lenses. Ind. J. Med Res., 73:472-473, 1981.

L-ErgoTM is a trademark of OXIS International, Inc, Portland, Oregon

Product # 26524 -
1. Miyoslu I, Sakai H. L-ergothimeme by microbial fermentation. IP patent 1968, number 450623 2
2. Yadan JC, Xu I., US Patent 5,438,151, 1995. Assignee: Oxis International
3. Hartman, P.E. L-ergothioneme as antioxidant. Meth Enzy 1990; 186.310-318.
4. Akanmu D. et al. The antioxidant action of l-ergothioneine. Arch Biochem Biophys 1991; 288: 10-16.
5. Aruoma OI et. al. Antioxidant Action of Ergothioneine: Assesment of Its Ability to Scanvenge Peroxynitrite. Biochem. Biophys. 1997; 231: 389-391
6. Aruoma O.I. Protection Against Oxidative Damage and Cell Death by the Natural Antioxidant Ergothioneine. Food & Chem Tox. 1999; 37: 1043-1053
7. Oxis Final Report, Preliminary toxicity study of ergothioneine/single dose study, June, 1997
8. Oxis Final Report, Preliminary toxicity study of ergothioneine 14 day study, June, 1997.
9. Melville D.B. L-ergothioneine. Vitam. & Hormone., 17:155?204.1958.
10. Shukla Y., Kulshrestha, O.P. and Khuteta K.P. L-ergothioneine content in normal and senile human cataractous lenses. Ind. J. Med Res., 73:472-473, 1981.

L-ErgoTM is a trademark of OXIS International, Inc, Portland, Oregon

Product # 26525 - 8
1.Takeuchi, T., and Morimoto, K. 1993. Carcinogenesis 14, 1115.
2.Csillag, C., and Aldhous, P. 1992. Science 258, 1875.
3.Mo, Y., et al. 1992. Proc. Natl. Acad. Sci. USA 89, 11021.
Product # 26526 -
1.Carini, R., et al. 1996. Biochem. Biophys. Res. Commun. 218, 772.
2.Li, L., et al. 1996. Toxicol. Appl. Pharmacol. 139, 135.
3.Siems, W.G., et al. 1996. Free Radic. Res. 20, 215.
4.Ullrich, O., et al. 1996. Free Radic. Res. 24, 421.
5.van Kuijk, F.J.G.M., et al. 1995. Anal. Biochem. 224, 420.
6.Esterbauer, H., et al. 1991. Free Radic. Biol. Med. 11, 81.
Product # 26527 - 3
1.Kooy, N.W., et al. 1995. Am. J. Respir. Crit. Care Med. 151,1250.
2.Ichiropoulos, H., et al. 1995. Am. J. Physiol. 269, L158.
3.Ichiropoulos, H., and al
Product # 26532 -
1.Szabo, C., et al. 1996. FEBS Lett. 381, 82.
2.Day B.J., et al. 1995. J. Pharmacol. Exp. Therap. 275, 1227.
3.Faulkner, K.M., et al. 1994. J. Biol. Chem. 269, 23471.
Product # 26534 - Morin Hydrate
1.Rice
Product # 26535 - NDGA, Larrea divaricata
1.Domin, J., et al. 1994. J. Biol. Chem. 269, 8260.
2.Goodman, Y., et al. 1994. Brain Res. 654, 171.
3.Kozubik, A., et al. 1993. Exp. Hematol. 21, 138.
4.Salari, H., et al. 1984. Prostagland. Leuk. Med. 13, 53.
5.Hope, W.C., et al. 1983. Biochem. Pharmacol. 32, 367.
Product # 26536 - Resveratrol
1.Jang, M., et al. 1997. Science 275, 218.
2.Chen, C.K., et al. 1996. Gen. Pharmacol. 27, 363.
Product # 26540 -
1.Salahudeen, A., et al. 1995. J. Am. Sao. Nephrol. 6, 1300.
2.Vollrath, B., et al. 1996. Cardiovasc. Res. 30, 619.
3.Wilson, J.T., et al. 1995. J. Trauma 39, 473.
Product # 26541 - VITAMIN E SUCCINATE
1.Turley, I.M., et all 996. Cell Growth Differentiation 8, 655.
2.Fariss, M.W., et al. 1994. Cancer Res. 54, 3346.
3.Cohrs, R.J., et al. 1991. Int. J. Dev. Neuroscl. 9, 187,
4.Sahu, S.N., and Prasad, K.N. 1988. Cancer 82, 949.
Product # 26543 - CAFFEIC ACID
1.Yamanaka, N., at al. 1997. FEBS Lett. 405,7186.
2.Chan, W.S., at al, 1995. Anticancer Res. 15, 703.
3.Ploemen, J.H., at al, 1993. Food Chem. Toxicol. 31, 475.
4.Koshihara, Y., at al. 1984. Biochim. Biophys. Acta 792, 92.
Product # 26544 - CAPE
1.Nicklaus M.C., et al. 1997 J. Med. Chem, 40, 920.
2.Natarajan, K., at al. 1996. Proc. Natl. Acad. W. USA 93, 9090.
Product # 26545 - Ferritin, Highly Purified, Equine Spleen
1.McDonald, M.J., et al. 1994. FASEB J. 8, 777.
2.Balla, G., et al. 1992, J. Biol. Chem. 267,18148.
3.Nelson, J.M., and Stevens, R.G. 1992. Cell Prolif. 25, 579.
4.Kirking, M,H. 1991. Clin. Pharmacol. 10, 776.
Product # 26571 -
1.Spencer, J.P.E., et al. 1995. FEBS Lett. 374, 233.
2.Park, E.
Product # 26592 -
1.Szabo, C., et al. 1996. FEBS Lett. 381, 82.
2.Day B.J., et al. 1995. J. Pharmacol. Exp. Therap. 275, 1227.
3.Faulkner, K.M., et al. 1994. J. Biol. Chem. 269, 23471.
Product # 27510 - Nitric Oxide Synthase, Rat Brain, Recombinant
1.Nakane, M., et al. 1995. Biochem. Biophys. Res. Commun. 206, 511.
2.Harteneck, C., et al. 1994. Biochem. J. 304, 683.
3.Richards, M.K., and Marletta, M.A. 1994. Biochemistry 33, 14723.
4.Charles, I.G., et al. 1993. Biochem. Biophys. Res. Commun. 196, 1481.
Product # 27511 - Nitric Oxide Synthase, Constitutive, Rat Neuronal, Recombinant
1.Abu-Soud, H.M., et al. 1994. J. Biol. Chem. 269, 32047.
2.Abu-Soud, H.M., et al. 1994. J. Biol. Chem. 269, 32318.
3.Richards, M.K., et al. 1994. Biochemistry 33, 14723.
4.Sheta, E.A., et al. 1994. J. Biol. Chem. 269, 15147.
Product # 27512 - Nitric Oxide Synthase, Constitutive, Rat Neuronal, Recombinant, High Purity
1.Abu-Soud, H.M., et al. 1994. J. Biol. Chem. 269, 32047.
Product # 27513 - Nitric Oxide Synthase, Inducible, Mouse Macrophage
1.Stevens
Product # 28718 -
1.Hattori, S., et al. 1995. Biochem. Mol. Biol. Int. 35, 177.
2.Mayeux, P.R., et al. 1995. Biochem. Pharmacol. 49, 115.
3.Norimatsu, M., et al. 1995. Infect. Immun. 63, 1122.
4.Feinstein, D.L., et al. 1993. J. Neurochem. 60, 1945.
5.Zhang, Y.H., et al. 1993. Infect.Immun. 61, 5044.
6.Jackson, S.K., et al. 1992. Biochim. Biophys. Acta 1135, 165.
7.O'Saliva, M.G., et al. 1992. J. Biol. Chem. 267, 14547.
8.Watanabe, K., et al. 1992. J. Cell. Physiol. 150, 433.
9.Morrison, D.C., and Ryan, J.L. 1987. Annu. Rev. Med. 38, 417.
Product # 29110 - Actinomycin D, Streptomyces sp.
1.Nakajima, M., et al. 1994. Neurosci. Lett. 176, 161.
2.Wu, M.H., and Yung, B.Y. 1994. Eur. J. Pharmacol. 270, 203.
3.Wu, M.H., and Yung, B.Y. 1994. Eur. J. Pharmacol. 270, 203.
4.Betzel, C., et al. 1993. Biochim. Biophys. Acta 1161, 47.
5.Yung, B.Y., et al. 1992. Int. J. Cancer 52, 317.
6.Martin, S.J., et al. 1990. J. Immunol. 145, 1859.
7.Yung, B.Y., et al. 1990. Cancer Res. 50, 5987.
8.White, R.J., and Phillips, D.R. 1985. Biochemistry 27, 9122.
9.Madharavao, M., et al. 1978. J. Med. Chem. 21, 958.
10.Sengupta, S.K., et al. 1975. J. Med. Chem. 18, 1175.
Product # 29111 - Aminoguanidine, Hemisulfate
1.Lazlo, F., et al. 1995. Eur. J.Pharmacol. 272, 169.
2.Wolfe, D.J., and Lubeskie, A. 1995. Arch. Biochem. Biophys. 316, 290.
3.Eaton, J.D., et al. 1993. Br. J. Pharmacol. 108, 128P.
4.Griffith, M.J.D., et al. 1993. Br. J. Pharmacol. 110, 963.
5.Ohrui, T., et al. 1992. J. Pharmacol. Exp. Therap. 261, 1268.
Product # 29112 - S
Stratman, N.C., et al. 1996. Life Sci. 59, 945.
Product # 29113 - Calpain Inhibitor I
1.Shinohara, K., et al. 1996. Biochem. J. 317, 385.
2.Griscavage, J.M., et al. 1995. Biochem. Biophys. Res. Commun. 215, 721.
3.Klafki, H.W., et al. 1995. Neurosci. Lett. 201, 29.
4.Squier, M.K., et al. 1994. J. Cell Physiol. 159, 229.
5.Rami, J., and Kreiglstein, J. 1993. Brain Res. 609, 67.
6.Sherwood, S.W., et al. 1993. Proc. Natl. Acad. Sci. USA 90, 3353.
7.Vinitsky, A., et al. 1992. Biochemistry 31, 9421.
8.Shenoy, A.M., and Brahmi, Z. 1991. Cell Immunol. 138, 24.
9.Sasaki, T., et al. 1990. J. Enzyme Inhib. 3, 195.
10.Tsujinaka, T., et al. 1988. Biochem. Biophys. Res. Commun. 153, 1201.
11.Yoshimura, T., et al. 1983. J. Biol. Chem. 258, 8883.
Product # 29120 - S
1.Krishnaswamy, N., et al. 1995. J. Biol. Chem. 270, 11103.
2.Furfine, E.S., et al. 1994. J. Biol. Chem. 269, 26677.
3.Narayanan, K., and Griffith, O.W. 1994. J. Med. Chem. 37, 885.

4.Sold under license of U.S. Patent 5,364,881 issued to the Medical College of Wisconsin Research Foundation, Inc.

Product # 29124 - L
1.Moore, W.M., et al. 1996. J. Med. Chem. 39, 669.
2.Connor, J.R., et al. 1995. Eur. J. Pharmacol. 273, 15.
3.Stenger, S., et al. 1995. Eur. J. Pharmacol. 294, 703.
4.Moore, W.M., et at. 1994. J. Med. Chem. 37, 3886.
5.Stuehr, D.J., and Griffith, O.W. 1992. Adv. Enzymol. 65, 287.
Product # 29126 - 7
1.Schulz, J.B., et al. 1995. J. Neurochem. 64, 936.
2.Klatt, P., et al. 1994. J. Biol. Chem. 269, 13861.
3.Wolff, D.J., et al. 1994. Arch. Biochem. Biophys. 314, 360.
4.Moore, P.K., et al. 1993. Br. J. Pharmacol. 110, 219.
5.Babbedge, R.C., et al. 1993. Br. J. Pharmacol. 110, 225.
6.Moore, P.K., et al. 1993. Br. J. Pharmacol. 108, 296.
Product # 29130 - 1,3
Garvey, E.P., et al. 1994. J. Biol. Chem. 269, 26669.
Product # 29132 - TRIM
1.Handy, R.L.C., et al. 1996. Br. J. Pharmacol. 119, 423.
2.Handy, R.L.C., et al. 1996. Br. J. Pharmacol. 117, 208P.
3.Harb, H.L., et al. 1996. Br. J. Pharmacol. 117, 280P.
4.Handy, R.L.C., et al. 1995. Br. J. Pharmacol. 116, 2349.
Product # 30110 - L
1.Schmidt, H.H., et al. 1992. Science 255, 721.
2.Sheng, H., et al. 1992. Br. J. Pharmacol. 106,768.
3.Garthwaite, J. 1991. Trends Pharmacol. Sci. 14, 60.
4.Jankeelov, J.A., Jr. 1970. Biochemistry 9, 2433.
Product # 30118 - S
1.Sandau, K., et al. 1996. Cell Signal. 8, 173.
2.Askew, S.C. 1995. Bioorg. Med. Chem.3, 1.
3.Fehsel, K., et al. 1995. J. Immunol. 155, 2858.
4.de Belder, A. J., et al. 1994. Cardiovasc. Res. 28, 691.
5.Sexton, D. J., et al. 1994. Photochem. Photobiol. 59, 463.
6.Singh, R. J., et al. 1994. Cardiovasc. Res. 28, 691.
7.Merryman, P. F., et al. 1993. Arthritis Rheum. 36, 1414.
8.Park, J. W., et al. 1993. Biochem. Mol. Biol. Int. 30, 885.
9.Radomski, M. W., et al. 1992. Br. J. Pharmacol. 107, 745.
Product # 30119 - S
Konorev, E.A., et al. 1996. Br. J. Pharmacol. 119,511.
Product # 30121 - SIN
1.Gergel, D., et al. 1995. J. Biol. Chem. 270, 20922.
2.de Groot, H., et al. 1993. FEBS Lett. 315, 139.
3.Lipton, S.A., et al. 1993. Nature 364, 626.
4.Drummer, C., et al. 1991. Thromb. Res. 63, 553.
5.Omar, B.A., et al. 1990. Free Radical Biol. Med. 9, 465
Product # 30123 - Spermine NONOate
1.Hogg, N., et al. 1996. Biochem. Biophys. Res. Commun. 224, 696.
2.Hrabie, J.A., et al. 1993. J. Org. Chem. 58, 1472.
3.Maragos, C.M., et al. 1993 Cancer Res. 53, 564.
4.Morley, D., and Keefer, L.K. 1993. J. Cardiovasc. Pharmacol. 22 (Suppl. 7) S3.
5.Wink, D.A., et al. 1993. Proc. Natl. Acad. Sci. USA 90, 9813.
6.Maragos, C.M., et al. 1991. J. Med. Chem. 34, 3242.
Product # 30125 - (
1.Ramirez, J., et al. 1996. Bioorg. Med. Chem. 6,2575.
2.Askew, S.C., et al. 1995. Bioorg. Med. Chem. 3, 1.
3.Fehsel, K., et al. 1995. J. Immunol. 155, 2858.
4.Gopalkrishna, R., et al. 1993. J. Biol. Chem. 268, 27180.
5.Southam, E., and Garthwaite, J. 1991. Neurosci. Lett. 130, 107.
6.Henry, P.J., et al. 1989. J. Pharmacol. Exp. Therap. 248, 762.
7.Ignarro, L.J., et al. 1981. J. Pharmacol. Exp. Therap. 218, 739.
Product # 30129 - Spermine NONOate
1.Hogg, N., et al. 1996. Biochem. Biophys. Res. Commun. 224, 696.
2.Hrabie, J.A., et al. 1993. J. Org. Chem. 58, 1472.
3.Maragos, C.M., et al. 1993 Cancer Res. 53, 564.
4.Morley, D., and Keefer, L.K. 1993. J. Cardiovasc. Pharmacol. 22 (Suppl. 7) S3.
5.Wink, D.A., et al. 1993. Proc. Natl. Acad. Sci. USA 90, 9813.
6.Maragos, C.M., et al. 1991. J. Med. Chem. 34, 3242.
Product # 31110 - Carboxy
1.Amano, F., and Nova, J. 1995. FEBS Lett. 368, 425.
2.Hogg, N., et al. 1995. Free RadicalRes. 22, 47.
3.Az-ma, T., et al. 1994. Life Sci. 54, 185.
4.Yoshida, M., et al. 1994. Biochem. Biophys. Res. Commun. 202, 923.
5.Akaike, T., et al. 1993. Biochemistry 32, 827.
6.Yoshida, K., et al. 1993. Infect. Immun. 61, 3552.

7.Sold under license of U.S. Patent

5,464,857 issued to Hiroshi Maeda.

Product # 31114 - (+)
1.Korkina, L.G., and Afanas'ev, I.B. 1997. Adv. Pharmacol. 38, 151.
2.van Acker, S.A., et al. 1995. Biochem. Biophys. Res. Commun. 214, 755.
Product # 32110 - Nitric Oxide Synthase (599
Michel, T., and Lamas, S. 1992 J. Cardiovasc, Pharmacol. 20, 545.
Product # 32111 - Inducible Nitric Oxide Synthase (1131
1.Lowenstein, C. J., et al. 1992. Pro. Natl. Accd. Sci USA 89, 6711.
2.Lyons, C. R., et al. 1992. J.Biol. Chem. 267, 6370.
Product # 33110 - L
1.Kamat, A., et al. 1995. Brain Res. Bull. 37, 233.
2.Bredt, D.S., and Snyder, S.H. 1989. Proc. Natl. Acad. Sci. USA 86, 9030.
Product # 33112 - L
1.Jornot, L., and Junod, A.F. 1995. Biochem. J. 306, 581.
2.Boles, J.O., et al. 1992. J. Biol. Chem. 267, 22217.
3.Nielson, J.B., and Anderson, O. 1992. Toxicology 74, 233.
Product # 33113 - Trolox
1.Saigo., M.G. and Pryor, W.A. 1996. Arch. Biochem. Biophys. 333, 482.
2.McLain, D.E., et al. 1995. FASEB J. 9,1345.
3.Saigo, M.G., et al. 1995. Arch. Biochem. Biophys. 322, 500.
4.Jovanovic, S.V., et al. 1994. J. Am. Chem. Soc. 116, 4846.

Trolox

Product # 59170AP -
1. Rogalla et al., Molecular Carcinogenesis 19 (1997) 153-156.
2. Sezer et al., European Journal of Cancer 36 (2000) 1944-1948.
3. Langelotz et al., British Journal of Cancer 88 (2003) 1406-1410.
Product # 59170D -
1. Rogalla et al., Molecular Carcinogenesis 19 (1997) 153-156.
2. Sezer et al., European Journal of Cancer 36 (2000) 1944-1948.
3. Langelotz et al., British Journal of Cancer 88 (2003) 1406-1410.
Product # 59210AP -
1. Rogalla et al., Molecular Carcinogenesis 19 (1997) 153-156.
2. Sezer et al., European Journal of Cancer
Product # 59210D -
1. Rogalla et al., Molecular Carcinogenesis 19 (1997) 153-156.
2. Sezer et al., European Journal of Cancer 36 (2000) 1944-1948.
3. Langelotz et al., British Journal of Cancer 88 (2003) 1406-1410.
Product # 70359 - Recombinant Human HMGA2 Fusion Protein
1. Rogalla et al., Molecular Carcinogenesis 19 (1997) 153-156.
2. Sezer et al., European Journal of Cancer 36 (2000) 1944-1948.
3. Langelotz et al., British Journal of Cancer 88 (2003) 1406-1410.
Product # BC-1129 -
1. Nicholls, S. and Hazen, S.: Myeloperoxidase and Cardiovascular Disease. Arterioscler Thromb Vasc Biol., 25:1102-1111(2005).

2. Olsen, R.L. and Little, C., Purification and some properties of myeloperoxidase and eosinophil peroxidase from human blood. Biochem. J. 209(3): 781-787 (1983).

3. Brennan, M., Penn, M., Van Lente, F., Nambi, V., Shishenbor, M., Ronnier, D.O., Aviles, J. Goormastic, M., Pepoy, M., McErlean, E., Topol, E., Nissen, S., and Hazen, S.: Prognostic Value of Myeloperoxidase in Patients with Chest Pain. New England Journal of Medicine. 349(17):1595-1604 (2003).

4. Nicholls, S. and Hazen, S.: The Role of Myeloperoxidase in the Pathogenesis for Coronary Artery Disease. Japan Journal of Infectious Diseases. 57(5):S21-2 (2004).

5. Baldus, S., Heeschen, C., Meinertz, T., Zeiher, A., Eiserich, J., Munzel, T., Simoons, M., Hamm, C., et. al.: Myeloperoxidase Serum Levels Predict Risk in Patients with Acute Coronary Syndromes. Circulation. 108:1440-1445 (2003).

6. Engall, E., Methods in Enzymology, Volume 70, Van Vunakais, H. and Langone, J. J.(eds.), Academic Press, New York, 419-492 (1980).

7. U.S. Department of Labor, Occupational Safety and Health Administration, 29 CRF Part 1910.1030. Occupational Exposure of Bloodborne Pathogens; Final Rule. Federal Register; 56 (235):64175 (1991).

8. USA Center for Disease Control/National Institute of Health Manual, "Biosafety in Microbiological and Biomedical Laboratories", (1984).